A Novel High-Content Screening Assay Identified Belinostat as Protective in a Focal Segmental Glomerulosclerosis-like Zebrafish Model

CONCLUSIONS: Using an FSGS-like zebrafish model, we developed a novel in vivo high-content screening assay that identified belinostat and related pan-HDAC inhibitors as potential candidates for treating …